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OBJECTIVE — We developed a ﬁeld procedure using personal digital assistant (PDA) tech-
nology to test the hypothesis that naturally occurring episodes of hypo- and hyperglycemia are
associated with deterioration in cognitive function in children with type 1 diabetes.
RESEARCH DESIGN AND METHODS — A total of 61 children aged 6–11 years with
type 1 diabetes received a PDA programmed with two brief cognitive tests (mental math and
choice reaction time), which they completed just before home glucose readings. The computer
recorded time to complete each test and number of correct responses. Children completed
several trials per day over 4–6 weeks for a total of 70 trials. Performance variables were com-
pared across glucose ranges. Individual impairment scores (IISs) were also computed for each
child by calculating the SD between performance during euglycemia and that during glucose
extremes.
RESULTS — Time to complete both mental math and reaction time was signiﬁcantly longer
during hypoglycemia. During hyperglycemia, time to complete math was signiﬁcantly longer
and reaction time was marginally signiﬁcant (P  0.053). There were no differences on task
accuracy.Declineinmentalmathperformancewasequivalentatglucoselevels3.0and22.2
mmol/l. IISs varied greatly across children, with no age or sex differences.
CONCLUSIONS — A decrease in mental efﬁciency occurs with naturally occurring hypo-
and hyperglycemic glucose ﬂuctuations in children with type 1 diabetes, and this effect can be
detectedwithaﬁeldprocedureusingPDAtechnology.Withbloodglucoselevels22.2mmol/l,
cognitive deterioration equals that associated with signiﬁcant hypoglycemia.
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I
n adults with type 1 diabetes, the neg-
ative impact of acute glucose extremes
oncognitiveandmotorfunctioniswell
documented. This is especially true for
the disruptive effects of hypoglycemia,
whichhavebeendemonstratedinnumer-
ous laboratory studies using insulin
clamp techniques (1–5) and in ﬁeld stud-
ies (6). More recently, there is growing
evidence that acute hyperglycemia can
also disrupt cognitive performance in
adults with both type 1 and type 2 diabe-
tes (6–8), although there are some dis-
crepant ﬁndings (5). Evidence for
cognitive deterioration has obvious clini-
cal implications for people living with
diabetes, many of whom experience
hypo- and hyperglycemia on a relatively
frequent basis. Such disruptions would
also have clinical signiﬁcance for children
with type 1 diabetes; however, surpris-
ingly few studies have examined these ef-
fects in pediatric populations. Only one
published laboratory study (9) tested the
impact of acute hypoglycemia in adoles-
cents and found that even with relatively
mild hypoglycemia (3.1–3.6 mmol/l),
mental efﬁciency signiﬁcantly decreased.
Two laboratory studies have examined
the impact of acute hyperglycemia in pe-
diatric patients with mixed results, with
oneﬁndingnoeffectinadolescentstested
at 20 mmol/l (10) and the other ﬁnding a
signiﬁcant decline at glucose levels above
20 mmol/l (11).
Onemajorbarriertoinvestigatingthe
effects of acute hypo- and hyperglycemia
on cognitive function in pediatric popu-
lations is reluctance to induce extreme
glucose levels, and possible neurological
insult, in younger patients with develop-
ing brains (12). However, glucose excur-
sionsmoreextremethanthoseinducedin
studies occur routinely outside of the lab-
oratory in children with type 1 diabetes.
Therefore, one way to bypass the ethical
problems that arise in neurocognitive re-
search involving pediatric patients is to
develop experimental procedures that
take advantage of these naturally occur-
ring hypo- and hyperglycemic episodes.
We have previously used personal digital
assistant (PDA) technology to investigate
the impact of daily hyperglycemia, in-
cluding postprandial increases, on cogni-
tiveperformanceinadultswithtype1and
type 2 diabetes (6,7). Patients performed
briefcognitivetestsonaPDAbeforehome
glucose measurements, repeating 50–70
trials over 1 month. A comparison of per-
formance during hyperglycemia (15
mmol/l) and euglycemia showed a signif-
icant decline at higher glucose levels.
Therewas,however,largeindividualvari-
ability in the effects of hyperglycemia,
with 50% of adults showing clinically
signiﬁcant disruption.
The purpose of this study was to de-
velop and test a similar computerized
ﬁeld procedure to assess cognitive perfor-
mance at different glucose levels in
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This ﬁeld procedure was then used to test
the hypothesis that children experience
signiﬁcant disruptions in cognitive per-
formance in their daily lives due to natu-
rally occurring episodes of both acute
hypo- and hyperglycemia. Children per-
formed two brief cognitive tests on a PDA
just before home glucose measurements
threetoﬁvetimesperdayoveraperiodof
1month,completingatotalof70trials.
Aftercompletingeachtest,childrenmade
subjective ratings of the difﬁculty of per-
forming the task to determine the degree
to which they were subjectively aware of
changes in cognitive function. Individual
impairment scores (IISs) were computed
for each child to examine relationships
between cognitive disruption and several
demographic and clinical variables,
including age, sex, diabetes duration, his-
tory of severe hypoglycemia, and meta-
bolic control.
RESEARCH DESIGN AND
METHODS— Children participating
in this study were taking part in a larger
project investigating family management
of diabetes, which required them to com-
plete surveys programmed on PDA com-
puters several times each day. Although
later phases of the larger project involved
interventions, including blood glucose
awarenesstraining,dataforthisstudywas
collected during an earlier phase of the
project that did not involve any interven-
tion.Familieswererecruitedforthestudy
through pediatric endocrine clinics at the
University of Virginia and Joslin Diabetes
Center in Boston, as well as through ad-
vertisements and regional parent support
groups. Inclusion criteria for children
wereage6–11years,adiagnosisoftype1
diabetes for at least 1 year, willingness to
performglucosemeasurements3–5times
daily, and ability to read, complete ques-
tionnaires, and use the PDA. Inclusion
criteria for parents included ability to
complete the study protocol, role as main
diabetes caregiver for the child, and the
absence of any self-reported signiﬁcant
psychiatric disorder, including depres-
sion and substance abuse. Eligible fami-
lies were invited to orientation meetings
during which the study was explained
and institutional review board–approved
informed consent/assent was obtained.
A total of 77 families entered the
study, and 66 parent-child pairs com-
pleted the protocol. Reasons for with-
drawal for nine families included
relocation, family stressors, and illness in
the child. Two other families withdrew
because the child did not want to con-
tinue completing the PDA surveys. For
two families, PDA data were lost in the
mail,andtheychosenottorepeatthepro-
cedure. An additional three families had
missing data that excluded them from
data analysis. Thus, the ﬁnal sample of
children with complete data was 61 (Uni-
versity of Virginia n  31, Joslin n  30).
Therewerenosigniﬁcantdemographicor
clinical differences between families who
completed and did not complete the
study. Children received a $35 toy or
bookstore gift card for completing data
collection.
The ﬁnal sample included 31 girls
and 30 boys, whose mean  SD age was
8.83  1.6 years and diabetes duration
was 4.7  2.6 years, with 25 children
aged 6–8 and 36 aged 9–11 years. A1C
measures ranged from 6.7 to 10.4%
(7.9  0.68%). No children had repeated
agradeinschool.Almostallfamilieswere
Caucasian (95%), and most parents had
at least some college education (mean
years of school: 15.8  2.6).
Questionnaires
Children completed the State-Trait Anxi-
ety Scale and the Children’s Depression
Inventory, measures that are widely used
in research, with well-documented reli-
ability and validity (13,14). Parents also
completed a questionnaire about the
child’sdiabeteshistory,includingthepast
frequency of mild, moderate, and severe
hypoglycemic episodes. Severe hypogly-
cemia was deﬁned for parents as episodes
during which their child was incapable of
self-treatmentoraskingfortreatmentdue
to mental confusion, stupor, uncon-
sciousness, or seizure. Moderate episodes
were deﬁned as those in which hypogly-
cemia signiﬁcantly disrupted routine or
ongoing behavior (e.g., the child could
notcontinuewithcurrentactivities).Mild
episodes were deﬁned as those associated
with warning symptoms that quickly re-
solved after treatment and did not signif-
icantly disrupt function. Parents reported
the frequency of severe and moderate ep-
isodes over the past year and reported the
frequency of mild episodes over the past
month.
Cognitive performance assessment
Families were provided with a Visor PDA
programmed with cognitive tests and
linked to a Freestyle Tracker BG meter to
collect and store glucose readings (Abbot
Diabetes Care, Abbott Labs, Alameda,
CA).Familieswereaskedtocomplete3–5
PDA trials each day, for a total of 70 trials
over the next 4–6 weeks. Children were
unable to complete trials unless the par-
entwaspresentandenteredapasswordto
start the program. After children com-
pleted the cognitive tests, the computer
instructed parents and children to mea-
sure glucose. All data were automatically
stored and time stamped, providing a va-
lidity check to insure that children com-
pleted cognitive tests before glucose
measurement.
The PDA presented two cognitive
tests, a mental math task and choice reac-
tion time. These tests were chosen based
on previous studies (3,6,7) showing that
these tasks were sensitive to cognitive-
motor disruptions in performance caused
by blood glucose extremes in adults. Both
tests were adapted for use by children.
The mental math task consisted of 10
math problems, 5 additions and 5 sub-
tractions, presented in random order.
Children entered their solution by tap-
pingnumbersdisplayedonanumberpad
on the screen. For children ages 6–8
years, math problems and solutions con-
tained only single-digit numbers. Chil-
dren aged 9–11 years were given math
problems containing one double-digit
number 20 and one single-digit num-
ber. In the choice reaction-time task, the
symbols for the four card suits (hearts,
diamonds, spades, and clubs) were
shown in color in the four corners of the
screen. One card suit would appear in the
center of the screen, and children
“tapped” the matching card suit in one of
the corners, with a total of 10 to match
presented in random order. The com-
puter tracked two performance mea-
sures, time to complete the task (in
seconds) and number of problems cor-
rect. After completing each task, chil-
dren rated their difﬁculty completing
the task (e.g., how hard it was) on a
visual analogue scale, where 0  not at
all and 6  very hard.
After orientation and informed con-
sent/assent, parents and children were
given Visor computers and Freestyle
meters and instructed on their use and
were also given, questionnaires to com-
plete and a stamped envelope for return-
ingdata.AfterreturnofPDAdata,ablood
sample kit was mailed to parents, who
obtained blood from their children and
returned the sample to the University of
Virginia Clinical Laboratories for A1C
measurement.
Cognitive function and children with diabetes
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Twodependentmeasureswerecomputed
for each cognitive test: 1) time (in sec-
onds) to complete the task (math time
and reaction time) and 2) number of cor-
rect responses (math correct and reaction
time correct). For math time and reaction
time, higher numbers indicate more sec-
onds to complete the task and therefore
poorer performance. For math correct
and reaction time correct, higher num-
bers indicate more accuracy and better
performance. The data were analyzed 1)
across subjects at different blood glucose
ranges to examine the impact of glycemic
statusoncognitivefunctionand2)within
subject, using Z scores, to determine
whether individual subjects showed dif-
ferences in the degree to which cognitive
function declined at glucose extremes.
For analyses across glucose levels, means
for performance measures were com-
puted for six clinically relevant ranges:
3.0 mmol/l (54 mg/dl), 3.0–3.8
mmol/l (54–69 mg/dl), 3.9–9.9 mmol/l
(70–179 mg/dl), 10–16.6 mmol/l (180–
299 mg/dl), 16.7–22.1 mmol/l (300–399
mg/dl), and 22.2 mmol/l (400 mg/
dl). The ranges 16.7–22.1 mmol/l and
higher than 22.2 mmol/l were speciﬁcally
chosen for investigation because, in the
state of Virginia, parents are called when
children’s glucose readings at school are
higher than 16.7 mmol/l and sent home
from school when readings are higher
than 22.2 mmol/l (15).
IISs were also computed for each
child,usingthechild’smeanperformance
during euglycemia (4.3–9.9 mmol/l) as
their individual baseline or “normal” per-
formance. The difference, in Z scores, be-
tween mean baseline performance and
mean performance during hypo- and hy-
perglycemia was then computed. IISs
were computed for blood glucose levels
3.0 and 22.2 mmol/l. Thus, these im-
pairment scores represented the mean
number of SDs between performance
during euglycemia and the most extreme
blood glucose levels. The calculation of
similar measures for individual impair-
mentinadultswithdiabeteshasbeenpre-
viously described in detail (6,7).
RESULTS
Performance across blood glucose
levels
Fig. 1 shows the means and SDs for each
of the four performance measures across
blood glucose ranges. There were signiﬁ-
cant main effects for math time (F  5.0,
P0.001)andastrongtrendforreaction
time (F  2.2, P  0.053). Contrasts
showed that compared with performance
at euglycemia, math time was signiﬁ-
cantly longer when blood glucose was
3.0 mmol/l (P  0.017) and 22.2
mmol/l (P  0.0001). Reaction time was
signiﬁcantly longer at glucose levels3.0
mmol/l (P  0.01), with a trend toward
signiﬁcance when blood glucose was
22.2 mmol/l (P  0.08). For both math
time and reaction time, seconds to task
completion did not differ for glucose lev-
els 3.0 and 22.2 mmol/l, indicating
that performance was equally poor in the
lowest and highest blood glucose ranges
for both tasks. Compared with perfor-
mance during euglycemia, math time was
anaverageof12.6and16.8slongerwhen
blood glucose levels were 3.0 and
22.2 mmol/l, respectively. Reaction
time was an average of 2.6 and 1.5 s
slower when glucose levels were 3.0
and 22.2 mmol/l, respectively. In con-
trast to the results for time to perform
tasks, there were no signiﬁcant differ-
ences in the number of correct responses
across ranges.
Exploratory analyses were also con-
ducted to identify practice effects over
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Figure 1—Mental math time and reaction time across blood glucose (BG) ranges.
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action time over the ﬁrst 35 trials were
compared with the second 35 trials at
each of the above three blood glucose
ranges:euglycemia(3.9–9.9mmol/l),hy-
poglycemia (3.0 mmol/l), and hyper-
glycemia (22.2 mmol/l). As expected,
during euglycemia math time was signif-
icantly shorter for the second of 35 trials
(56.9vs.66.8s;F19.6,P0.001),but
there was no improvement for reaction
time(P0.13).Whenbloodglucosewas
3.0or22.2mmol/l,therewerenosig-
niﬁcant differences in math time or reac-
tion time between the ﬁrst and second
half of the study, indicating no practice
effects over time.
Perceived difﬁculty of task
performance
Mean difﬁculty ratings tended to be low
across all blood glucose ranges; however,
signiﬁcant differences were still found.
For the math task, average ratings were
0.44, 0.77, and 0.58 for euglycemia, hy-
poglycemia, and hyperglycemia, respec-
tively,withasigniﬁcantmaineffectacross
blood glucose levels (F  4.3, P 
0.0001). Mean difﬁculty ratings for the
reaction time task were 0.15, 0.40, and
0.13, respectively, which also differed
across blood glucose levels (F  3.9, P 
0.001). However, contrasts showed that
for both tasks, difﬁculty ratings were sig-
niﬁcantly higher only when glucose was
3.0 mmol/l (P  0.01). This indicates
that children perceived greater difﬁculty
performing tasks during hypoglycemia
but not when glucose levels were 22.2
mmol/l, even though time to complete
tasks increased signiﬁcantly and equiva-
lently at both blood glucose extremes.
Individual differences
To examine individual differences in the
impact of hypo- and hyperglycemia on
performance, IISs were computed as de-
scribed above for math time at blood glu-
cose levels 3.0 and 22.2 mmol/l.
These scores were only computed for
those children who had blood glucose
readings 3.0 mmol/l (n  34) or 22.2
mmol/l (n  41). Positive Z scores indi-
catedpoorerperformancecomparedwith
euglycemia,andnegativescoresindicated
better performance. Mean IIS for math
time when blood glucose was 3.0 and
22.2 mmol/l were 0.57  1.6 and
0.33  1.1, respectively. There were no
sexoragedifferencesinIISateitherhypo-
or hyperglycemia. A total of 21% of chil-
dren had IISs higher than 1.0, indicating
that performance deteriorated on average
1 SD when blood glucose was 3.0
mmol/l. When blood glucose was 22.2
mmol/l, 27% of children showed this de-
gree of decline.
Exploratory correlations were com-
puted between IIS and several clinical
variables. Separate correlations were
computed for glucose ranges 3.0 and
22.2 mmol/l. Impairment scores were
not related to diabetes duration, blood
glucse variability (as determined by sev-
eral measures including the interquartile
range, low and high blood glucose risk
indexes), or depression and anxiety mea-
sures. The child’s A1C correlated with
impairmentscoresforreactiontimewhen
blood glucose was 22.2 mmol/l (r 
0.40, P  0.02), indicating more impair-
ment with poorer diabetes control. Num-
ber of severe hypoglycemic episodes over
the past year correlated with impairment
scores for both math time (r  0.39, P 
0.04) and reaction time (r  0.40, P 
0.02) when blood glucose was 22.2
mmol/l,indicatingthatmorefrequentep-
isodes were associated with more impair-
ment. Neither A1C nor frequency of
severe hypoglycemia correlated with per-
formance impairment exhibited when
blood glucose was 3.0 mmol/l.
CONCLUSIONS— Based on these
ﬁndings, naturally occurring episodes of
acute hypo- and hyperglycemia during
daily routine can be associated with cog-
nitive-motor disruptions in school-aged
children with diabetes. To our knowl-
edge, this is the ﬁrst study comparing the
negative impact of hypo- and hyperglyce-
miaoncognitivefunctioninthispediatric
population. Somewhat surprisingly, the
decline in performance at both glucose
extremes was equivalent. However, a sig-
niﬁcant decline in performance was not
seen until hyperglycemia became quite
profound. In addition, blood glucose ex-
tremes affected only the time to complete
tasks and not the number of correct re-
sponses. This ﬁnding replicates results
from adult studies (2,3) and adds to the
data suggesting that the initial effect of
blood glucose extremes is a decrease in
mental efﬁciency and speed and not a de-
crease in accuracy. Thus, people with di-
abetes of all ages may compensate
behaviorally for blood glucose–related
cognitive disruptions by ﬁrst slowing
down their performance and conse-
quently sacriﬁcing efﬁciency to preserve
accuracy. A similar type of behavioral
compensation plays a key role in models
of aging and cognitive functioning (16).
The extent to which people with dia-
betes are subjectively aware of these ef-
fects remains unclear and is an important
area for ongoing research. In this study,
children were aware that they were hav-
ing more difﬁculty completing tasks dur-
ing hypoglycemia but not during
hyperglycemia,eventhoughperformance
was equally affected. However, children’s
difﬁculty ratings were also extremely low
(average 1.0 on a six-point scale) across
all blood glucose ranges, which may indi-
cate that they were reluctant to acknowl-
edge problems in their performance. In a
previous article (17), we have reported
that young children show very poor abil-
ity to recognize mild to moderate hypo-
glycemia,failingtodetectonaverageover
40% of blood glucose readings 3.0
mmol/l. Given this, it is somewhat sur-
prising that children in this study showed
some awareness of increased difﬁculty
performing the tasks when blood glucose
levels were low.
Although this study found statisti-
cally signiﬁcant differences in perfor-
manceatbloodglucoseextremes,itisalso
important to consider whether the ob-
served level of deterioration is clinically
signiﬁcant.Oneapproachtothisquestion
is to examine the degree of disruption by
whatever objective standards are avail-
able. During euglycemia, it took children
an average of just over 1 min to complete
10 relatively simple mental math prob-
lems. During hypo- and hyperglycemia,
respectively, this task took an average of
12 and 16 seconds longer to com-
plete, representing an 20% decrease in
speed. It is not difﬁcult to imagine that a
20% decrease in mental efﬁciency could
be clinically meaningful, especially with
more complex, demanding, or time-
consuming tasks. Another approach to
this question is to evaluate the number of
individual children who showed effects
that might be considered clinically signif-
icant. In this study, IISs indicated that
performance declined 1 SD during hy-
po- and hyperglycemia for 20% of
children.
The ﬁnding that children varied
greatly in the extent to which they were
affected by glucose extremes replicates
ﬁndings from studies of adults with dia-
betes (3,6). The mechanisms underlying
theseindividualdifferencesinvulnerabil-
ity remain difﬁcult to identify. In this
study, demographic variables such as age
and sex were not associated with individ-
Cognitive function and children with diabetes
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to examine the role of clinical variables
indicated that higher A1C levels and fre-
quency of severe hypoglycemia may be
related to more impairment when blood
glucose levels are very high. This ﬁnding
is in contrast to the predictions some cli-
nicians would make based on anecdotal
evidence that type 1 diabetic individuals
who are in better glycemic control expe-
rience more symptomatology and disrup-
tion with hyperglycemia. Neither A1C or
history of severe hypoglycemia were re-
lated to the degree of impairment dur-
ing hypoglycemia. Obviously, more
research with much larger numbers of
children is needed to gather more con-
clusive information regarding risk fac-
tors for acute blood glucose–related
cognitive disruption.
More research is also needed to iden-
tify the neurobiological mechanisms
underlying the impact of acute hypergly-
cemia on cognitive function. While the
effect of neuroglycopenia secondary to
hypoglycemia is well deﬁned, there is
controversy about the neurological effect
ofhyperglycemia.However,therearesev-
eral possibilities including microvascular
dysfunction in the blood-brain barrier
and alterations in the synthesis, availabil-
ity, or reuptake of neurotransmitters,
such as serotonin (18). Recent studies
have identiﬁed a signiﬁcant reduction in
theplasmafreefractionof L-tryptophanin
children with type 1 diabetes, as well as
differences in auditory cortical responses
between children with and without dia-
betes, which may indicate brain differ-
ences in serotonergic neurotransmission
(19,20). Other recent studies show that
changes in extracellular brain glucose
have a direct effect on orexin neurons in
the lateral hypothalamus, which play a
critical role in the regulation of wakeful-
ness and arousal (21).
Another purpose of this study was to
determine whether PDA procedures
could provide an alternative ﬁeld method
for studying cognitive function in chil-
dren at different blood glucose levels.
Two questions need to be addressed for
this purpose: feasibility and efﬁcacy. In
terms of feasibility, it appears that in gen-
eral children can successfully perform re-
peated trials of brief PDA-administered
cognitive tests over a period of several
weeks. Of 77 families who entered the
study, 78% completed the protocol. In
terms of efﬁcacy, the mental math task
appears to be sensitive enough to detect
differences in children’s cognitive perfor-
mance associated with glycemic ex-
tremes. This replicates ﬁndings in
previous studies of adults with diabetes
(5,6) and indicates that even relatively
simple tasks requiring working memory
and problem solving can be disrupted by
hyperglycemia. The reaction time task
showed less sensitivity to the disruptive
effects of blood glucose extremes and also
no practice effects during euglycemia,
which may indicate that it was not com-
plexordifﬁcultenough.Failuretoﬁndan
effect on performance accuracy may also
have occurred because of a ceiling effect
for these relatively easy tasks, which were
designed to avoid producing psychologi-
calburdenandfrustrationfortheseyoung
children. Future studies need to incorpo-
rate more complex and demanding cog-
nitive tasks, while balancing the need to
not overburden pediatric populations.
The current study has several impor-
tant methodological limitations that
should be considered when interpreting
these ﬁndings. First, we tested a relatively
small number of children over a relatively
short period of time, which yielded a lim-
ited number of extreme blood glucose
readings to analyze. Only 56 and 67% of
the children had blood glucose values in
the lowest and highest ranges, respec-
tively,fordataanalysis.Futurestudiesare
neededtotestalargernumberofchildren
over a longer time period, or for repeated
short periods over longer time, to capture
moremeasuresofperformanceduringex-
treme blood glucose ﬂuctuations. In ad-
dition, future studies would beneﬁt
greatly by using continuous glucose-
monitoring devices in order to obtain a
more comprehensive picture of glucose
dynamics preceding cognitive testing.
This approach would allow, for example,
the opportunity to assess the impact of
blood glucose variabililty and of anteced-
ent episodes of hypo- and/or hyperglyce-
mia on cognitive function. Finally, this
study is limited by testing a fairly homog-
enoussampleofalmostallCaucasianchil-
dren with well-educated parents.
Even with these limitations, the ﬁnd-
ing that routinely occurring episodes of
acute hypo- and hyperglycemia can dis-
ruptcognitivemotorfunctioninchildren,
and that the impact of signiﬁcant hyper-
glycemia equals that of signiﬁcant hypo-
glycemia, has important implications.
Nonetheless, these ﬁndings should be
considered preliminary and interpreted
with great caution. For example, these
ﬁndings should not be interpreted as ev-
idence that children’s cognitive perfor-
mance cannot be affected by blood
glucose levels 22.2 mmol/l. Nor are
these ﬁndings evidence that all children
willexperiencesigniﬁcantimpairmentsat
22.2 mmol/l. This study found large indi-
vidual differences in degree of impair-
mentatdifferentbloodglucoselevels,and
there are likely numerous, unidentiﬁed
variables that inﬂuence the impact of an
episode of acute hyperglycemia on cog-
nitive function. What these ﬁndings do
strongly indicate is that more research
into the effects of acute hyperglycemia
on cognitive function in children is
warranted.
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